Skip to search formSkip to main contentSkip to account menu

ulipristal

Known as: 11-beta-(4-(dimethylamino)phenyl)-17-hydroxy-19-norpregna-4,9-diene-3,20-dione, 17alpha-acetoxy-11beta-(4-N,N-dimethylaminophenyl)-19-norpregna-4,9-diene-3,20-dione 
A selective progesterone receptor modulator with anti-progesterone activity. Ulipristal binds to the progesterone receptor (PR), thereby inhibiting… 
National Institutes of Health

Related topics

Related topics

8 relations

Narrower (4)

CDB 2914EllaVA-2914ulipristal acetate
elective Progesterone Receptor Modulators [MoA]ulipristal acetate 30 MGulipristal acetate 30 MG Oral Tablet [Ella]ulipristal acetate 5 MG

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Emergency Contraception Access and Counseling in Urban Pharmacies: A Comparison between States with and without Pharmacist Prescribing
Pharmacists are often the primary source of emergency contraception (EC) access and patient information. This study aims to… 
2018
2018
Development of a Novel Computerized Clinical Decision Support System to Improve Adolescent Sexual Health Care Provision
OBJECTIVE The objective was to develop an acceptable clinical decision support (CDS) system to facilitate evidence-based sexual… 
2016
2016
[The morning after pill, a necessary scientific discussion].
2013
2013
Axitinib dose titration: what's the limiting factor?
Review
2013
Review
2013
Cost-effectiveness of increased access to emergency contraceptive pills: probably not.
2010
2010
Intrauterine administration of CDB-2914 (Ulipristal) suppresses the endometrium of rhesus macaques.
2010
2010
ULIPRISTAL ACETATE- A NOVEL ORAL EMERGENCY CONTRACEPTIVE: HYPE OR HOPE?
Unintended pregnancy is a global reproductive health concern. Although emergency contraception is meant to be used after an… 
Review
2010
Review
2010
Ulipristal. Postcoital contraception: no better than levonorgestrel.
  • Prescrire international
  • 2010
  • Corpus ID: 6741939
Postcoital contraception, also known as emergency contraception, is currently based on a single 1.5 mg dose of levonorgestrel, a… 
Review
2007
Review
2007
Ulipristal, a progesterone receptor antagonist as a contraceptive and for the treatment of uterine fibroids.
HRA Pharma, under license from the Research Triangle Institute, is developing ulipristal, a progesterone receptor modulator, for… 
Review
2003
Review
2003
Pharmacologic properties of CDB(VA)-2914
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)